TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
<p>Background. Chronic myelogenous leukemia (CML) is a malignant clonal disorder of hematopoietic stem cell. In majority of patients we find reciprocal chromosomal translocation t (9.22) which result in fusion oncoprotein with tyrosine kinase activity. The normal ABL protein is involved in the regul...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Slovenian Medical Association
2004-12-01
|
| Serier: | Zdravniški Vestnik |
| Fag: | |
| Online adgang: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2419 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|